Australia and New Zealand Assisted Reproduction Database
Fertility clinics submit data to the NPESU each year as part of their licencing requirements under the Reproductive Technology Accreditation Committee (RTAC) Code of Practice.
ANZARD includes information on in vitro fertilisation (IVF) cycles, including intracytoplasmic sperm injection (ICSI) cycles using fresh and cryopreserved (frozen) embryos, and laboratory techniques such as preimplantation genetic testing and extended embryo culture. ANZARD also collects information on all donor insemination cycles performed in Australian and New Zealand Clinics where partner sperm is used.
Demographic details on female and male patients, such as age and infertility diagnosis. and the pregnancy and birth outcomes from each cycle of treatment are recorded.
The most recent ANZARD Annual Report (2019) can be found at the link below.
ANZARD was established as a collaborative effort of the National Perinatal Epidemiology and Statistics Unit (NPESU), the Fertility Society of Australia (FSA) and the fertility centres in Australia and New Zealand.
The first years of data collection were for ART treatments performed in 2002. ANZARD supersedes the Assisted Conception Data Collection (ACDC), which contains information on the outcomes of clinical pregnancies resulting from assisted conception in Australia and New Zealand from its commencement in 1979.
The purpose of the ANZARD collection is to inform patients, the medical community and governments about ART treatments performed in Australia and New Zealand.
ANZARD monitors ART treatment practices, success rates and perinatal outcomes which are published annually as part of an Annual Reports Series. It is also used to benchmark the performance of clinics both nationally and internationally and provide a rich source of data for undertaking research.
The new version of the Data Dictionary is ANZARD 3.0 and was developed in consultation with a number of clinics and endorsed by the FSA Board and IVF Directors in 2018. It is also currently being fully piloted by a number of sites.
ANZARD 3.0 will accommodate same sex and single intending parents, collect better prognostic and diagnostic information, and collect more detailed information on PGT and cryopreservation. The definition of different ART cycle types has also been refined to remove the ambiguity that currently exists.